Literature DB >> 15346155

Intravenous Valproate for Pediatric Status Epilepticus.

Elizabeth Waterhouse.   

Abstract

Entities:  

Year:  2003        PMID： 15346155      PMCID： PMC321226          DOI： 10.1046/j.1535-7597.2003.03612.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  4 in total

1.  Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus.

Authors:  M A Uberall; R Trollmann; U Wunsiedler; D Wenzel
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

2.  Intravenous valproate is well tolerated in unstable patients with status epilepticus.

Authors:  S Sinha; D K Naritoku
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

3.  The safety of rapid valproic acid infusion.

Authors:  N A Limdi; E Faught
Journal:  Epilepsia       Date:  2000-10       Impact factor: 5.864

4.  Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients.

Authors:  V Venkataraman; J W Wheless
Journal:  Epilepsy Res       Date:  1999-06       Impact factor: 3.045
  4 in total
  2 in total

1.  Valproic acid prevents glucocorticoid‑induced osteonecrosis of the femoral head of rats.

Authors:  Ding Zhou; Yi-Xuan Chen; Jun-Hui Yin; Shi-Cong Tao; Shang-Chun Guo; Zhan-Ying Wei; Yong Feng; Chang-Qing Zhang
Journal:  Int J Mol Med       Date:  2018-03-06       Impact factor: 4.101

2.  Hydrogel contained valproic acid accelerates bone-defect repair via activating Notch signaling pathway in ovariectomized rats.

Authors:  Zhou-Shan Tao; Tian-Lin Li; Hong-Guang Xu; Min Yang
Journal:  J Mater Sci Mater Med       Date:  2021-12-23       Impact factor: 3.896
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.